Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma

Activating BRAF mutations have recently been reported in 28-83% of papillary thyroid carcinomas (PTCs). However, it is not known whether aberrant BRAF splicing occurs in thyroid carcinoma. To investigate aberrant BRAF splicing and its association with BRAF mutation in thyroid tumours, we studied abe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pathology 2009-04, Vol.217 (5), p.707-715
Hauptverfasser: Baitei, Essa Y, Zou, Minjing, Al-Mohanna, Futwan, Collison, Katharine, Alzahrani, Ali S, Farid, Nadir R, Meyer, Brian, Shi, Yufei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!